Psychosocial Impairment
15
1
1
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
8%
1 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (15)
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
Evaluation of Quality of Life and Psychosocial Status in Children With Inflammatory Bowel Disease
rTMS for Emotional Difficulties in Verterans
Child and Adolescent Psychiatric Personality Structure
Stroke Telemedicine Outpatient Prevention Program for Blood Pressure Reduction
The Effect of Roy Adaptation-Based Nursing Intervention
The PaTHS Descriptive Correlational Longitudinal Study
Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders
Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus Pandemic
Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia
Comparison of Physical and Psychosocial Characteristics of Pectus Excavatum and Carinatum Patients With Healthy Controls
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia
Youth FORWARD Phase 1 YRI and EPP Study
The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia